Consolidated revenues increased 43% year-over-year to $64.3 million with telehealth revenue up 60%
● Adjusted EBITDA increased 78% to $9.0 million
● Telehealth adjusted EBITDA increased 396% to $5.9 million
● Full-year cash flow from operations increased 99% to $17.5 million and generated positive full-year net cash flow
● Exited 2024 with over $35 million in cash
● Introduces 2025 guidance for consolidated revenue of $265 million to $275 million and consolidated adjusted EBITDA of $30 million to $32 million
LifeMD Q4 Adj EPS $(0.02) Beats $(0.05) Estimate
Sales $64.25M Beat $57.38M Estimate
LifeMD Sees Q1 Revenue $61M-$63M Vs $59.447M Est.
FY25 Revenue $265M-$275M Vs $257.23M Est